Alveolar bone loss is associated with circulating anti-citrullinated protein antibody (ACPA) in patients with rheumatoid arthritis

Shawneen M. Gonzalez, Jeffrey B. Payne, Fang Yu, Geoffrey M. Thiele, Alan R. Erickson, Paul G. Johnson, Marian J. Schmid, Grant W. Cannon, Gail S. Kerr, Andreas M. Reimold, Jeremy Sokolove, William H. Robinson, Ted R. Mikuls

Research output: Contribution to journalArticlepeer-review

36 Scopus citations


Background: This study examines: 1) alveolar bone loss (ABL), a hallmark of periodontitis, in anticitrullinated protein antibody (ACPA)-positive rheumatoid arthritis (RA) patients versus control patients with osteoarthritis (OA); and 2) the association of ABL with RA disease activity and ACPA concentrations, including multiple antigen-specific ACPA. Methods: This multicenter case-control study includes 617 patients diagnosed with RA (n = 287) or OA (n = 330). Panoramic radiographs were taken; patients were categorized into low, moderate, or high tertiles based on mean percentage ABL. Serum ACPA was measured using second-generation anticyclic citrullinated peptide enzyme-linked immunosorbent assay and a multiplex platform to assess distinct antigen-specific ACPA. A generalized linear mixed model for binary data was used to compare stratified ABL in RA versus OA patients. Associations of moderate and high ABL (versus low) with RA disease activity and severity measures were examined using multivariate regression. Antigen-specific ACPA responses were compared among ABL tertiles using significance analysis of microarrays. Results: ACPA-positive patients with RA had a significantly higher mean percentage of sites with ABL >20% compared with patients with OA (P = 0.03). After multivariate adjustment, greater ABL was significantly associated with higher serum ACPA concentration (P = 0.004), 28-joint Disease Activity Score (P = 0.023), health assessment questionnaire disability (P = 0.05), tender joint count (P = 0.02) and joint space narrowing scores (P = 0.05) among patients with RA. ACPAs targeting citrullinated vimentin and histone were significantly higher in moderate and high ABL groups versus low, regardless of smoking status (q <0.1%). Conclusions: Greater ABL was associated with higher ACPA, consistent with findings at articular sites. ACPA targeting could provide novel insight into important linkages between RA and periodontitis.

Original languageEnglish (US)
Pages (from-to)222-231
Number of pages10
JournalJournal of Periodontology
Issue number2
StatePublished - Feb 1 2015


  • Alveolar bone loss
  • Arthritis, rheumatoid
  • Histones
  • Peptides, cyclic
  • Periodontitis
  • Vimentin

ASJC Scopus subject areas

  • Periodontics


Dive into the research topics of 'Alveolar bone loss is associated with circulating anti-citrullinated protein antibody (ACPA) in patients with rheumatoid arthritis'. Together they form a unique fingerprint.

Cite this